1. Power, Derek, Santoso, Netty, Dieringer, Michael, Miao, Hongyu, Zhu, Jian. 2015. IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency. In Virology, 481, 142-50. doi:10.1016/j.virol.2015.02.046. https://pubmed.ncbi.nlm.nih.gov/25776761/
2. Elsayed Ramadan Genena, Shaimaa, Hamouda, Maha A F, Salama, Norhan M, Abdel Latif, Asmaa A, Dawood, Ashraf A. 2024. Interferon-induced protein 44 (IFI44) and interferon regulatory factor 4 (IRF4) gene expression in rheumatoid arthritis. In Journal of immunoassay & immunochemistry, 45, 432-451. doi:10.1080/15321819.2024.2381524. https://pubmed.ncbi.nlm.nih.gov/39051937/
3. Wei, Bowen, Yue, Qingyun, Ka, Yuxiu, Wu, Yuanhao, Liu, Wei. 2024. Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome. In Journal of inflammation research, 17, 5723-5740. doi:10.2147/JIR.S477490. https://pubmed.ncbi.nlm.nih.gov/39219820/
4. Zheng, Qingcong, Wang, Du, Lin, Rongjie, Lv, Qi, Wang, Wanming. 2022. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. In Frontiers in immunology, 13, 1013322. doi:10.3389/fimmu.2022.1013322. https://pubmed.ncbi.nlm.nih.gov/36189314/
5. Wang, Yuan, Ma, Chengfeng, Ma, Zhanbing, Huo, Zhenghao, Dang, Jie. 2023. Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis. In Journal of inflammation research, 16, 3219-3231. doi:10.2147/JIR.S419880. https://pubmed.ncbi.nlm.nih.gov/37547125/